These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 11591099)

  • 1. Methods for the detection of anti-neutrophil cytoplasmic antibodies. Recommendations for clinical use of ANCA serology and laboratory efforts to optimize the informative value of ANCA test results.
    Wiik A
    Springer Semin Immunopathol; 2001; 23(3):217-29. PubMed ID: 11591099
    [No Abstract]   [Full Text] [Related]  

  • 2. ANCA: anti-neutrophil cytoplasmic antibodies and their role in vasculitis associated kidney disorders.
    Badakere SS; Pradhan VD
    Indian J Med Sci; 2002 Jul; 56(7):335-9. PubMed ID: 12645170
    [No Abstract]   [Full Text] [Related]  

  • 3. Antineutrophil cytoplasmic antibody (ANCA) testing: Audit from a clinical immunology laboratory.
    Phatak S; Aggarwal A; Agarwal V; Lawrence A; Misra R
    Int J Rheum Dis; 2017 Jun; 20(6):774-778. PubMed ID: 27457216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing and reporting antineutrophil cytoplasmic antibodies (ANCA) in treated vasculitis and non-vasculitic disease.
    Savige J; Trevisin M; Pollock W
    J Immunol Methods; 2018 Jul; 458():1-7. PubMed ID: 29486145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CARI guidelines. ANCA serology in the diagnosis and management of ANCA-associated renal vasculitis.
    Luxton G; Langham R;
    Nephrology (Carlton); 2008 Jul; 13 Suppl 2():S17-23. PubMed ID: 18713120
    [No Abstract]   [Full Text] [Related]  

  • 6. A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies.
    Savige JA; Paspaliaris B; Silvestrini R; Davies D; Nikoloutsopoulos T; Sturgess A; Neil J; Pollock W; Dunster K; Hendle M
    J Clin Pathol; 1998 Aug; 51(8):568-75. PubMed ID: 9828813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of antineutrophil cytoplasmic antibodies and glomerular basement membrane antibodies in the diagnosis and monitoring of systemic vasculitides.
    Sinclair D; Stevens JM
    Ann Clin Biochem; 2007 Sep; 44(Pt 5):432-42. PubMed ID: 17761028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interpretation of ANCA serology.
    Halfpenny CA; Douglas RG
    N Z Med J; 1999 Mar; 112(1083):65-6. PubMed ID: 10210305
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.
    Hagen EC; Daha MR; Hermans J; Andrassy K; Csernok E; Gaskin G; Lesavre P; Lüdemann J; Rasmussen N; Sinico RA; Wiik A; van der Woude FJ
    Kidney Int; 1998 Mar; 53(3):743-53. PubMed ID: 9507222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of a symptom related "gating policy" on ANCA requests in routine clinical practice.
    Sinclair D; Saas M; Stevens JM
    J Clin Pathol; 2004 Feb; 57(2):131-4. PubMed ID: 14747434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory diagnostics in vasculitis patients.
    Wiik A
    Isr Med Assoc J; 2001 Apr; 3(4):275-7. PubMed ID: 11344841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antineutrophil cytoplasmic autoantibodies in systemic vasculitis].
    Hagemo JS; Aasarød K; Moen T
    Tidsskr Nor Laegeforen; 2002 May; 122(12):1185-8. PubMed ID: 12089844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of classical and atypical antineutrophil cytoplasmic antibody (ANCA) immunofluorescence patterns.
    Wong RC; Silvestrini RA; Savige JA; Fulcher DA; Benson EM
    J Clin Pathol; 1999 Feb; 52(2):124-8. PubMed ID: 10396240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Positivity of antineutrophil cytoplasmic antibodies in children: prevalence and etiologies].
    Jerbi A; Feki S; Ben Ameur S; Hachicha H; Gargouri L; Kamoun T; Mahfoudh A; Hachicha M; Masmoudi H
    Ann Biol Clin (Paris); 2018 Jan; 76(1):68-74. PubMed ID: 29386146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-neutrophil cytoplasmic antibodies tests: which tests should be used in practice?
    Wiik A
    Intern Med; 2001 Jun; 40(6):466-70. PubMed ID: 11446667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical value of antineutrophil cytoplasmic antibodies.
    Rus V; Handwerger BS
    Curr Rheumatol Rep; 2000 Oct; 2(5):383-9. PubMed ID: 11123087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic value of anti-neutrophil cytoplasmic antibody testing in a routine clinical setting.
    McLaren JS; Stimson RH; McRorie ER; Coia JE; Luqmani RA
    QJM; 2001 Nov; 94(11):615-21. PubMed ID: 11704691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunofluorescent patterns produced by antineutrophil cytoplasmic antibodies (ANCA) vary depending on neutrophil substrate and conjugate.
    Pollock W; Clarke K; Gallagher K; Hall J; Luckhurst E; McEvoy R; Melny J; Neil J; Nikoloutsopoulos A; Thompson T; Trevisin M; Savige J
    J Clin Pathol; 2002 Sep; 55(9):680-3. PubMed ID: 12194998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antineutrophil cytoplasm antibody: positivity and clinical correlation.
    Martínez Téllez G; Torres Rives B; Rangel Velázquez S; Sánchez Rodríguez V; Ramos Ríos MA; Fuentes Smith LE
    Reumatol Clin; 2015; 11(1):17-21. PubMed ID: 24913965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New aspects of antineutrophil cytoplasmic antibody (ANCA) diagnosis in vasculitis].
    Csernok E; Reichel P; Gross WL
    Z Rheumatol; 2002 Aug; 61(4):367-77. PubMed ID: 12426842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.